ascendis pharma glp-1 receptor agonist weight management diabetes treatments Ozempic maker Novo Nordisk is working on a once-monthly weight-loss drug Understanding GLP-1 receptor agonists and

A.Toft-NielsenM.PridalL.WillmsB.HolstJ

Biomarker-driven personalization Matching the right drug to the right patient One of the most exciting developments is the use of biomarkers, measurable biological indicators, to predict how a patient will respond to therapy

Closely related patents are grouped into families, and the priority date refers to the date when the first member of a given family is filed

The small-molecule GLP-1RA estate will have many more lifecycle-extension opportunities for the originator

The Mediterranean diet has demonstrated consistent benefits for cardiometabolic health in clinical studies

Kinlen D, Cody D, OShea D